A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years. Click here to read the article now.
Wayne Ray, PhD, from the Vanderbilt University School of Medicine, and coauthors, used national Medicaid data from 2004-2013 to identify patients beginning antipsychotic treatment and calculated the incidence of NMS during antipsychotic use. The investigators identified five factors that independently predicted increased NMS incidence: age 18-24 years; schizophrenia spectrum and other psychotic disorders; neurodevelopmental disorders; antipsychotic dose >200 mg chlorpromazine-equivalents; and first-generation antipsychotics.
“Patients with 4 or 5 of these factors had more than 100 times the incidence of those with none,” reported the investigators.
“These data provide a basis for early identification of children and youth at elevated risk for NMS for whom monitoring for signs of this life-threatening syndrome could be increased, potentially leading to earlier detection and improved outcomes.”
Paul E. Croarkin, DO, MS, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology, states: “Neuroleptic Malignant Syndrome is rare, serious, and previously understudied in children and adolescents. This important paper by Dr. Ray and colleagues has illuminated risk factors with immediate utility for clinical practice and provided a foundation for future research.”
About the Journal
Journal of Child and Adolescent Psychopharmacology is an authoritative peer-reviewed journal published bimonthly in print and online. The Journal is dedicated to child and adolescent psychiatry and behavioral pediatrics, covering clinical and biological aspects of child and adolescent psychopharmacology and developmental neurobiology. Complete tables of content and a sample issue may be viewed on the Journal of Child and Adolescent Psychopharmacology website.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.
END
Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth
2024-09-18
(Press-News.org)
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Levels of protection from different cycle helmets revealed by new ratings
2024-09-18
Cyclists choosing a new helmet can see how much protection different helmets offer, thanks to new safety testing and ratings from Imperial College London.
Researchers at Imperial College London have developed a simple new cycle helmet safety rating system with simple-to-understand scores from 0-5, designed to help buyers select which helmet to buy and assist manufacturers in future helmet design. The system is based on extensive new safety testing experiments on medium-sized helmets at Imperial.
Testing on the UK’s 30 most popular helmets, funded by The Road Safety Trust, revealed significant ...
Pupils with SEND continue to fall behind their peers
2024-09-18
Pupils with special educational needs and disabilities (SEND) are continuing to fall behind their peers with the gap widening despite the introduction of SEND legislation.
This is according to a new study by Durham University which analysed data on 2.5 million Year 6 pupils across four school years from 2014-2019.
The research suggests there is a need to re-evaluate the policies for SEND provision and how pupils with SEND are supported in schools.
It calls for more investment to support SEND pupils and for increased professional development for teachers and teaching assistants.
Using ...
Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits
2024-09-18
Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits
Just over half of heavier drinkers in England say they would make changes to their drinking if calorie labels for alcohol were introduced, according to a new study by UCL researchers.
The findings, the researchers said, suggested calorie labels could help some drinkers maintain a healthier weight.
The study, published in the journal BMJ Open, looked at survey responses from 4,683 adults in England to assess the impact that alcohol calorie labelling might have on people’s attitudes and drinking ...
Study first to link operating room design to shorter surgery
2024-09-18
LAWRENCE – Xiaobo Quan is proud that his study is the first of its kind to link operating room design to the length of knee- and hip-replacement surgeries.
Thus, the University of Kansas School of Architecture & Design associate professor believes its findings can be used to optimize spaces that will both produce better outcomes, via shorter surgeries, for patients and boost the hospital’s bottom line.
For the article “Can Operating Room Design Make Orthopedic Surgeries Shorter, Safer, and More Efficient?: A Quasi-Experimental Study,” ---------- link to: https://doi.org/10.1177/19375867241254529 --------- in the journal Health Environments Research & Design, ...
New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis
2024-09-18
A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.1
The findings, presented today at ECTRIMS 2024, suggest that concerns related to pregnancy may lead to delayed or reduced use of disease-modifying treatments (DMTs), even before pregnancy becomes a consideration.
In an extensive analysis of 22,657 patients with relapsing MS (74.2% women) who were on the French ...
Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer
2024-09-18
With publicly funded correlative science in the nation’s Cancer Cooperative Groups reduced to a trickle, Group leaders propose implementing a long-standing National Academy of Medicine recommendation to bring new money to this area of research through public-private partnerships. They also recommend major process changes to remove significant barriers for researchers to access the biological samples contributed by patients. The current Journal of Clinical Oncology issue features ‘Correlative Science in the Cooperative Group System—Re-Engineering for Success.’
This Position Paper represents consensus among Evanthia Galanis, MD, DSc for the Alliance for Clinical ...
Nawaz named ASME Fellow
2024-09-18
Kashif Nawaz, distinguished researcher and section head for Building Technologies Research at the Department of Energy’s Oak Ridge National Laboratory, has been named a Fellow of the American Society of Mechanical Engineers, or ASME. The Fellow grade recognizes outstanding engineering achievements for members with 10 or more years of active practice.
Nawaz joined ORNL in 2016 as a research scientist in buildings equipment. He specializes in the heating, cooling and dehumidification systems of buildings including the development of novel heat exchangers and enhanced phase-change material ...
U2opia signs license to commercialize anomaly-detection technology for cybersecurity
2024-09-18
U2opia Technology has licensed Situ and Heartbeat, a package of technologies from the Department of Energy’s Oak Ridge National Laboratory that offers a new method for advanced cybersecurity monitoring in real time. Situ, which discovers and understands otherwise-undetectable events by analyzing security data, will go to the market through a commercial license. The company will continue to explore opportunities for Heartbeat, which detects cyber attacks by focusing on the physical behavior of a protected device, through a research and development license.
U2opia Technology, a woman- and minority- led company, is directed by Maurice Singleton III, chief executive officer, ...
Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event
2024-09-18
Some of the most dramatic climatic events in our planet’s history are “Snowball Earth” events that happened hundreds of millions of years ago, when almost the entire planet was encased in ice up to 0.6 miles (1 kilometer) thick.
These “Snowball Earth” events have happened only a handful of times and do not occur on regular cycles. Each lasts for millions of years or tens of millions of years and is followed by dramatic warming, but the details of these transitions are poorly ...
Cleveland Clinic study is first to show success in treating rare blood disorder
2024-09-18
Wednesday, September 18, 2024, CLEVELAND: A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in 5,000 people worldwide. The trial, led by Keith McCrae, M.D., of Cleveland Clinic and supported by the National Institutes of Health, was stopped early because of these successful findings, and has been published in the New England Journal of Medicine.
The impetus for this trial was a single patient. About ...